The Evaluation of Banana Flower Stamens Extract on Prevention of Benign Prostatic Hyperplasia in Adults
The Evaluation of Banana Flower Stamens Extract on Prevention of Benign Prostatic Hyperplasia in Adults
To assess the evaluation of banana flower stamens extract on prevention of benign prostatic
 hyperplasia in adults
This is a double-blind and randomized study. Subjects are informed to consume the samples
 every day for 2 months. The clinical diagnosis item of benign prostatic hyperplasia (BPH) is
 evaluated by the doctor. The questionnaires are collected at every visit of the trial.
Inclusion Criteria:

 1. Male aged 40-80 years old

 2. 7 ≤ IPSS score <19

 3. The subject did not take α-blocker or anticholinergic agents in the last 8 weeks. The
 subject did not take 5α-reductase inhibitor or androgen suppression agents in the last
 16 weeks (depending on medical history).

 4. The subject isn't diagnosed with cancer

 5. The subject is able to read and finish the information on the questionnaire.

 6. The subject must read and sign the informed consent form after the study has been
 fully explained.

 Exclusion criteria:

 1. The subject has a history of epilepsy or convulsions, liver and kidney disease,
 cancer, endocrine disease, mental illness, alcohol or drug abuse, and other major
 organic diseases (depending on medical history).

 2. The lower urinary tract urination symptoms of the subject are not related to prostatic
 hypertrophy (depending on medical history).

 3. Residual urine volume > 250 mL (depending on medical history)

 4. Subjects have had pelvic radiation therapy or pelvic surgery (including prostate or
 bladder surgery, but those who only have had a prostate slice can participate in the
 trial).

 5. Subjects have taken sexual hormone preparations including LHRH agonists,
 anti-androgens, feminine, or Penta-reductase inhibitors (Proscar and Avodart) 16 weeks
 prior to the trial.

 6. Subjects have participated in other clinical trials 12 weeks prior to the trial.